HW211026

· Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HW211026, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of HW211026 in Participants With Actinic Keratosis [Phase 2]